Any current/future new fundraising through debt or equity?

The company has planned a capex of Rs. 250 crores for the current year (FY’26), which is already being factored into their debt levels. Management indicated no significant capital expenditure is planned for the next 18 months beyond this, implying no major immediate debt increase. Debt levels are currently near peak; reduction in net debt is expected in the coming years as there are no new large capex plans. No mention was made of any planned equity fundraising during the call or in the transcript. The focus appears to be on consolidating current investments and leveraging new capacity

Any current/future capex/capital investment/strategic investment?

The company planned Rs. 250 crores capex for the current year (FY’26), which includes commissioning two new lines in Q4 FY’26 and Q1 FY’27 as part of this capex. Two additional new lines are under commissioning; one line expected in Q4 FY’26 and another in Q1 FY’27. After this planned capex, the company is entering a consolidation phase with no major further capex planned for the rest of FY’26 and for the next year. The new film lines are more cost-efficient and expected to improve competitiveness. Specialty Chemical Subsidiary is developing new coating products expected to be commerci

Future growth expectations in sales/revenue/volumes?

FY’26 revenue guidance is Rs. 3500 to Rs. 3800 crores, with specialty films contributing Rs. 2200 to Rs. 2500 crores of that. The company expects volume growth driven by ramping up newly commissioned BOPP lines, targeting close to full utilization by Q4 FY’26. Specialty and semi-specialty film volumes aimed to increase from ~18-20% in Q2 to around 70% over the next 12-24 months. New specialty product launches and expansion in consumer segments like window films, paint-protection films, and ceramic coatings are expected to scale revenue. Specialty Chemicals subsidiary is growing with ne

Future growth expectations in earnings/operating earnings/profits/EPS?

The new BOPP line, with a nameplate capacity of 81,000 metric tons, is ramping up and expected to achieve full utilization by Q4 FY’26, aiding growth in volumes and margins. Specialty and semi-specialty films are targeted to constitute close to 70% of volumes over the next 12 months, up from 18-20% in Q2 FY’26, supporting higher-margin sales. The company expects the specialty portfolio revenue to be between Rs. 2200 to Rs. 2500 crores within an overall turnover of Rs. 3500 to Rs. 3800 crores in FY’26. Cost advantages from newer lines are expected to reduce variable costs by around 15%. Special

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or pending orders for Cosmo First Limited. However, the company reports: - New BOPP line with nameplate capacity of 81,000 metric tons, ramping up with close to two-thirds utilization in Q2 and expected near full utilization by Q4 FY’26. - Specialty and semi-specialty films currently around 18-20% of volume, targeting close to 70% in next 12 months. - Specialty chemical vertical growing profitably. - New product launches planned in specialty films. - Positive demand outlook with balanced supply-demand for B

IN US

Sale is live|00:00:00left today

Cosmo First LtdQ3 FY25Industrial Products

Cosmo First Ltd Q3 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹822P/E: 13.7Market Cap: ₹2.0K CrSector: Industrial Products

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 2

→FY’26 revenue guidance is Rs. 3500 to Rs. 3800 crores, with specialty films contributing Rs. 2200 to Rs. 2500 crores of that.
→The company expects volume growth driven by ramping up newly commissioned BOPP lines, targeting close to full utilization by Q4 FY’26.
→Specialty and semi-specialty film volumes aimed to increase from ~18-20% in Q2 to around 70% over the next 12-24 months.
→New specialty product launches and expansion in consumer segments like window films, paint-protection films, and ceramic coatings are expected to scale revenue.
→Specialty Chemicals subsidiary is growing with new products launching in next two quarters, posting record EBITDA.
→Rigid packaging (Cosmo Plastech) aims to improve capacity utilization beyond 70%.
→Pet care (Zigly) business is growing but profitability expected in 3-4 years post scaling.
→Overall, growth focus is on expanding specialty products, exports, and leveraging new investments for cost reduction.

Margin guidance

Category 3

→The new BOPP line, with a nameplate capacity of 81,000 metric tons, is ramping up and expected to achieve full utilization by Q4 FY’26, aiding growth in volumes and margins.
→Specialty and semi-specialty films are targeted to constitute close to 70% of volumes over the next 12 months, up from 18-20% in Q2 FY’26, supporting higher-margin sales.
→The company expects the specialty portfolio revenue to be between Rs. 2200 to Rs. 2500 crores within an overall turnover of Rs. 3500 to Rs. 3800 crores in FY’26.
→Cost advantages from newer lines are expected to reduce variable costs by around 15%.
→Specialty chemical vertical is already profitable and growing; rigid packaging and consumer segments focus on growth and profitability.
→Zigly (pet care retail) expected to take 3-4 years to reach profitability.
→Debt levels to stabilize in FY’26 with reduced capex, potentially improving financial metrics.
→EBITDA impacted by tariffs and imports, but improving margin trends and higher volumes should boost future earnings.

3 more insights locked — sign up free to unlock

Fundraise plans

→The company has planned a capex of Rs. 250 crores for the current year (FY’26), which is already being factored into their debt levels.
→Management indicated no significant capital expenditure is planned for the next 18 months beyond this, implying no major immediate debt increase.
→Debt levels are currently near peak; reduction in net debt is expected in the coming years as there are no new large capex plans.
→No mention was made of any planned equity fundraising during the call or in the transcript.
→The focus appears to be on consolidating current investments and leveraging new capacity rather than raising new funds.

Order book

→The transcript does not explicitly mention the current or expected order book or pending orders for Cosmo First Limited.
→However, the company reports:
→ - New BOPP line with nameplate capacity of 81,000 metric tons, ramping up with close to two-thirds utilization in Q2 and expected near full utilization by Q4 FY’26.
→ - Specialty and semi-specialty films currently around 18-20% of volume, targeting close to 70% in next 12 months.
→ - Specialty chemical vertical growing profitably.
→ - New product launches planned in specialty films.
→ - Positive demand outlook with balanced supply-demand for BOPP segment over next 2-3 years.
→Management focuses on growing specialty films and leveraging new capacity, suggesting healthy order inflow and expected demand growth, though specific order book values are not disclosed.

Capex plans

Yes

→The company planned Rs. 250 crores capex for the current year (FY’26), which includes commissioning two new lines in Q4 FY’26 and Q1 FY’27 as part of this capex.
→Two additional new lines are under commissioning; one line expected in Q4 FY’26 and another in Q1 FY’27.
→After this planned capex, the company is entering a consolidation phase with no major further capex planned for the rest of FY’26 and for the next year.
→The new film lines are more cost-efficient and expected to improve competitiveness.
→Specialty Chemical Subsidiary is developing new coating products expected to be commercialized over the next two quarters, indicating strategic investment in innovation.
→The company is focused on leveraging new investments to grow specialty films and reduce costs.
→Renewable power usage targets to increase to about two-thirds of power consumption within 12-15 months for cost rationalization.

How does Cosmo First Ltd rank vs peers in Industrial Products?

Pro feature

1Cosmo First Ltd

Rev 2Mar 3

See full Industrial Products sector rankings

Want more stocks like Cosmo First Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio